Tkxel的动态

#Apax's Zellis Eyes Benify Acquisition in European Tech Surge In a significant move for the European technology sector, Zellis, backed by Apax Partners, is nearing a deal to acquire the employee benefits platform Benify. This acquisition is part of an accelerating trend in tech deal-making across Europe. The deal, reportedly valued at several hundred million dollars, is expected to be announced soon. Vitruvian Partners, Benify's current owner, acquired the platform back in 2011, and the company now serves over 3 million users. With Apax's recent acquisition of Zellis from Bain Capital for ￡1.25 billion, this new potential acquisition further positions Zellis as a key player in the industry. As the European tech sector heats up, what could this mean for future market dynamics? #Zellis #ApaxPartners #Benify #TechAcquisition #EuropeanTech #MarketTrends #EmployeeBenefits #SaaSverse

???In our latest video, Donal O'Shea, CEO of digital pathology company, Deciphex, and Brian Geraghty, Principal at Claret give a brief snapshot of?Deciphex's?innovative solutions that are revolutionising the industry. Hear from Donal as he also tells us: ? ???Why venture debt was attractive as a non-dilutive funding option to support their growth journey ???Why they chose Claret, and how we've supported the business as they continue to scale ? "Since Claret has become involved with?Deciphex, we've scaled our reach in international markets, we've grown our commercial organisations, we've grown in scale revenue. We've had the ability to do that through access to capital." Donal O'Shea, CEO of Deciphex. ? Watch the?video?here! ? #venturedebt #growth #digitalpathology #innovation

I'll see you in #LSIUSA25 to discuss accelerating clinical trial and product development timelines in #MedTech.

Yesterday, our staff enterprise team hosted Scottish Enterprise and the Maxitope Team for a project kick off meeting and lively discussion of the next steps to build the company, product, and pipeline towards launch in 2025. Maxitope, a startup on the Scottish Enterprise High growth Spinout programme, has developed a promising new way to improve target selection for antibodies and immunotherapies to develop more effective treatments. The team have successfully completed an ICURe program and will be refining their market and customer engagement while building up the team and pipeline. Scottish Enterprise| Jonathan Dempsey| Nick Gilbert | Patrick Kearns | Charles Dixon | Kristina Tamane| Axel Thomson

After the celebration for the CODiE award as Best Marketing Solutions (https://lnkd.in/eT5d5_J4 ), we're continuing on our path to drive engineering excellence to enable marketers. But we believe the award also reflects the benefits of a novel business model: openness, integration, enablement. Our guiding principle is to be an accelerant on top of existing (Mar)tech, on surgical areas where full access to the code base can be a differentiator. With no recurring licensing. See more here https://lnkd.in/daWEaYx2 #BCGX #Fabriq #Personalization #MarTech

Neurent Medical, a Galway-based medtech firm, secured €9 million in growth capital from Claret Capital to fund its U.S. expansion. ServiceTitan's IPO on Nasdaq priced at $71 per share, closing at $101, indicating strong market demand for VC-backed firms. The defense sector anticipates increased M&A activity as companies invest in AI and space technologies. #MedTech #IPO #DefenseIndustry

Opyl announces a transformative joint venture with X Firm, set to revolutionize clinical trial outcomes and increase market reach across EMEA and North America. Read More https://lnkd.in/giSHdbKm #JointVenture, #TrialKey, #fundingRaise, #clinicalTrials, #marketExpansion

#investor insights in #dtx at LSX - partnering for Life Science eXecutives Join me at 5 today in London to talk with 5 incredible minds about investments in the DTx space: Shamik J Parekh Ingrid Teigland Akay, MD MBA Erki M?lder Josep Ll. Sanfeliu Dominick Kennerson And let me know if you want to further the conversation before or after the panel!

We don't just say we are making a difference, we actually make it happen. ?? See how Brainlab has made an impact since founded in 1989. Learn more about us here: https://lnkd.in/gRbTPjTs #medtech #WeAreBrainlab

hVIVO has posted record revenues of ￡62.7m, up 12%, as it expands into Germany with a ￡10m acquisition. The clinical trials firm is eyeing ￡100m in revenue by 2028—can it reach its goal?